Science Comedy, Shifting Rules For Abortion Pills. Jan 6, 2023, Part 1

Science Comedy, Shifting Rules For Abortion P...

Suivant

Why is brain cancer so hard to treat?

Brain cancers are rare, but devastating. Patients face short life expectancies after diagnosis. Brain tumors are often impossible to remove completely. And radiation and chemotherapy don’t always stop them from spreading. It’s a daunting class of disease to study, but that didn’t ...  Afficher plus

How can astronaut food be better?

Astronaut food is not known as a frontier of culinary imagination, unless you count rehydrated shrimp cocktail. As NASA prepares for longer trips to the moon and Mars, is space cuisine ready for an overhaul? Flora speaks with retired astronaut Clayton Anderson, who spent 167 days ...  Afficher plus

Épisodes Recommandés

Abortion Pills, Take Two
Radiolab

Abortion pills — a combo of two drugs, mifepristone and misoprostol — are on notice: on April 7, 2023, a federal judge said the FDA’s approval of mifepristone was invalid. And then, not more than an hour later, another federal judge in a separate case said that mifepristone ha ...

  Afficher plus

A Little Bit Pregnant
Invisibilia

This week on Invisibilia, could the rebrand of a familiar pill open up a new way to control fertility in a post-Roe America?See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Pri ...  Afficher plus

Mail-Order Pharmacy Dispensing of Mifepristone for Abortion After In-Person Screening
JAMA Internal Medicine Author Interviews

Interview with Daniel Grossman, MD, author of Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening, and Emily M. Godfrey, MD, MPH, author of Primary Care's Role in Prescribing Mail-Order Mifepristone. Hosted by Eve Rittenberg, MD. Relat ...  Afficher plus

The Abortion Pill Legal Standoff Endangers Access to All Drugs
Science, Spoken

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications. Read the story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices